Guardant Health, Inc. (GH) Earnings History
Net Loss10 years of earnings data (2016–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Guardant Health, Inc. (GH) Earnings Overview
As of June 21, 2026, Guardant Health, Inc. (GH) reported trailing twelve-month net income of -$433M, reflecting +6.7% year-over-year growth. The company earned $-3.30 per diluted share over the past four quarters, with a net profit margin of -42.4%.
Looking at the long-term picture, GH's historical earnings data spans multiple years. The company achieved its highest annual net income of -$46M in fiscal 2016.
Guardant Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including EXAS (-$208M net income, -6.4% margin), ILMN ($853M net income, 19.6% margin), NTRA (-$226M net income, -9.0% margin), GH has room to improve margins relative to the peer group. Compare GH vs EXAS →
GH Earnings vs Peers
Earnings metrics vs comparable public companies
GH Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$416M | +4.6% | -$436M | $-3.32 | -42.4% | -44.4% |
| 2024 | -$436M | +9.0% | -$444M | $-3.56 | -59.0% | -60.0% |
| 2023 | -$479M | +26.8% | -$565M | $-4.28 | -85.0% | -100.1% |
| 2022 | -$655M | -61.4% | -$544M | $-6.41 | -145.6% | -121.1% |
| 2021 | -$406M | -59.8% | -$411M | $-3.80 | -108.6% | -110.0% |
| 2020 | -$254M | -235.5% | -$255M | $-2.53 | -88.5% | -88.9% |
| 2019 | -$76M | +11.1% | -$82M | $-0.75 | -35.3% | -38.4% |
| 2018 | -$85M | -2.2% | -$93M | $-1.00 | -93.8% | -102.5% |
| 2017 | -$83M | -80.4% | -$77M | $-1.18 | -167.0% | -153.7% |
| 2016 | -$46M | - | -$44M | $-3.49 | -182.7% | -173.7% |
Download Data
Export GH earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into GH consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GH — Frequently Asked Questions
Quick answers to the most common questions about buying GH stock.
What is GH earnings per share (EPS)?
GH trailing twelve-month (TTM) diluted EPS is $-3.30, reflecting +6.7% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2016 to 2025 is available in the table on this page.
What is Guardant Health, Inc.'s net income?
Guardant Health, Inc. (GH) trailing twelve-month net income is $-433M as of 2025. Earnings grew +6.7% year-over-year.
Is GH profitable?
GH is not currently profitable on a TTM basis, reporting a net loss of $-433M. Net margin is -42.4%. Investors should monitor for a return to profitability.
What is GH's earnings growth rate?
GH compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2016 to 2025.
What are GH's profit margins?
Guardant Health, Inc. net profit margin is -42.4%, operating margin is -44.4%, and gross margin is +64.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is GH growing earnings?
GH is growing earnings steadily. YoY EPS growth of +6.7% is consistent with the 5-year CAGR of N/A. TTM net income is $-433M.
What was GH's best earnings year?
Guardant Health, Inc.'s highest annual net income on record is $-46M, achieved in fiscal year 2016. Earnings history on this page spans 2016 to 2025 and includes all annual and quarterly figures.
What were GH's earnings last quarter?
GH's most recent reported quarter was Q1 2026. Net income was $-112M with diluted EPS of $-0.85. For a full breakdown of all quarters, see the quarterly earnings table on this page.